In cancer cells, TGF-β performs a dual role via SMAD to either promote tumor suppression or inactivate the immune system to promote tumorigenesis that leads to changes in cell differentiation, causing epithelial–mesenchymal transition (EMT) [33]. This evidence concerns the gene TGFB1 and neoplasm.